Navigation Links
United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program
Date:10/24/2007

rtnership,

net of tax (206) (39) 155 533

Net income before

discontinued

operations 24,098 21,065 72,519 59,344

Discontinued operations,

net of tax (118) 11,024 2 10,777

Net income $23,980 $32,089 $72,521 $70,121

Weighted average shares

outstanding - basic 37,229 36,680 37,185 36,637

Weighted average shares

outstanding - diluted 37,521 37,098 37,513 37,090

Net income per share

- basic $0.64 $0.87 $1.95 $1.91

Net income per share

- diluted $0.64 $0.86 $1.93 $1.89

Combined ratio analysis:

Loss ratio 55.8 55.1 56.7 57.8

Expense ratio 32.5 31.7 32.1 31.9

Combined ratio 88.3 86.8 88.8 89.7

Certain prior period amounts have been reclassified to conform to the 2007

presentation. Earnings per share includes results of discontinued

operations. The presentation above is not in conformity with generally

accepted accounting principles (GAAP) which requires earnings per share

for discontinued operations to be disclosed separately.

UNITED AMERICA INDEMNITY, LTD.

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share data)

ASSETS As of As of

September 30, December 31,

2007 2006

Bonds:

Available for sale securities,

at fair value (amortized cost: 2007

-
'/>"/>

SOURCE United America Indemnity, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
4. United Kingdom to perform its first Live Liver Transplant
5. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
6. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
7. Bird-Flu Causes Alarm in United Kingdom.
8. 2010 AIDS Target May Misfire, Warns United Nations
9. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
10. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
11. Chinese Poultry Smuggled into United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...gist explains prevalence of winter diaper rash and...sh season , COLLEGEVILLE, Pa., Dec. 2 /PRNewsw...per-clad babies, the winter months can mean cute l...nd not-so-cute and oh-so-painful little red bottom... until sunscreen season comes around again. , ...
(Date:12/2/2008)...alif., Dec. 2 The natio...oday to President-elect Obama urging him to fulfil...le and available by allowing any American to join ...a that a proposal pushed by health insurance compa...h insurance policies "amounts only to a government...
(Date:12/2/2008)...dy finds natural, less expensive treatments are ef... , PRINCETON, N.J., Dec. 2 Wi...oliday season is, for most, anticipated with excit... who suffer from Irritable Bowel Syndrome (IBS), t... embarrassing and debilitating gastrointestinal at...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
Breaking Medicine News(10 mins):Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2
...00 personnel of the Central Reserve Police Force (...en found to be addicted to drugs and alcohol// , a...the survey to find out the number of men who have ...ound 426 alcohol and drug addicts," said a senior ...
...esearchers have discovered that fatty acid ethyl e...iably portray the extent of fetal alcohol exposure...e if an infant has been exposed to alcohol during ...trictly associated with alcohol use," said Enrique...
...e sector YES Bank has signed an MoU with a leading... up a 75-100 million dollar health care fund cater...hs. // The Netherlands-based equity house will ru...ank would be the advisor. This would be its first ...
...ing to a new study, men with prostate cancer are m...ional changes, which prevents them //from trustin...isconceptions on the disease management options an...f others with prostate cancer to their own conditi...
Other Medicine News:Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits greater radial dilation in the ureter. The Unidex handle facilitates easy, ergonomic one-handed operation.
Used to establish and maintain nephrostomy drainage following pyeloplasty. The open ureteral segment promotes patency and allows the stent to adjust as edema subsides. Supplied sterile in peel-open p
Medicine Products: